Atlas Trials

Bicyclol in the Treatment of Antineoplastic Drug-induced Liver Injury.

Clinical trial NCT05711459 · UNKNOWN

Trial details

NCT number
NCT05711459
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Drug-Induced Acute Liver Injury
Start date
2022-05-01
Primary completion
2023-05-01
Enrollment
5405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.